Merck pharmaceutical operations, vaccines, oncology medicines, and global research presence within the s&p 500 healthcare sector, highlighting development, manufacturing, and distribution activities ...

The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...

Q4 2025 Press Conference Call March 5, 2026 4:00 AM ESTCompany ParticipantsAxel LoberBelén Garijo López - Chair of Executive Board ...

We're obviously very excited to have Elanco here with us today, and representing the company is Bob VanHimbergen, who's the Chief Financial Officer of the company; and to his left, Bobby Modi, who is ...

This article discusses the best dividend mutual funds to buy right now.

German healthcare firm Merck KGaA is boosting investments in China, aiming for strategic collaborations with local companies.

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Last month, large pharmaceutical conglomerate Merck filed a worker adjustment and retraining notification (WARN) notice with ...

Global supply chains are entering a new phase. In his latest Forbes Business Council article, "Why Capability-Not Geography-Will Define the Next Decade of Trade," Morten Johansen, COO of DP World in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.